Luxonus Overview
- Year Founded
-
2018

- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
16
Luxonus General Information
Description
Developer of photoacoustic technology designed to provide early detection and diagnosis of diseases. The company's image diagnostic device can take ultra-high-resolution three-dimensional (3D) images of blood vessels and lymphatic vessels safely and easily without exposure by using optical ultrasonic imaging technology that combines light and ultrasonic waves, enabling doctors to avail a comprehensive understanding of the onset of disease, the healing process, and pre-and post-illness health conditions.
Contact Information
Website
www.luxonus.jpCorporate Office
- AIRBIC, A22
- 7-7 Shinkawasaki, Saiwai-ku
- Kawasaki, Kanagawa 212-0032
- Japan
Corporate Office
- AIRBIC, A22
- 7-7 Shinkawasaki, Saiwai-ku
- Kawasaki, Kanagawa 212-0032
- Japan
Luxonus Timeline
Luxonus Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Accelerator/Incubator | Completed | Generating Revenue | ||||
4. Later Stage VC | 01-Jan-2023 | Completed | Generating Revenue | |||
3. Early Stage VC (Series B) | 20-May-2022 | Completed | Generating Revenue | |||
2. Early Stage VC (Series B) | 10-Sep-2021 | $3.89M | $9.5M | Completed | Startup | |
1. Early Stage VC (Series A) | 21-Nov-2019 | $5.56M | $5.56M | Completed | Startup |
Luxonus Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Luxonus Patents
Luxonus Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2023139380-A | Data compression device, data compression program, data compression method, data expansion device, data expansion program, and data expansion method | Pending | 22-Mar-2022 | ||
JP-2023050881-A | Image processing device, image processing method and recording medium | Pending | 30-Sep-2021 | ||
US-20240423587-A1 | Image generating method, image generating program, and image generating apparatus | Pending | 27-Sep-2021 | ||
JP-2023036499-A | Image processing apparatus, image processing method, and recording medium | Pending | 02-Sep-2021 | ||
JP-2022034766-A | Image forming method, image forming program, and image forming device | Active | 19-Aug-2020 |
Luxonus Investors (16)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
IT-Farm | Venture Capital | Minority | ||
360ip Japan | Venture Capital | Minority | ||
Mirai Creation Capital | Venture Capital | Minority | ||
Mirai Souzou Investments | Venture Capital | Minority | ||
Future Venture Capital | Venture Capital | Minority |
Luxonus FAQs
-
When was Luxonus founded?
Luxonus was founded in 2018.
-
Where is Luxonus headquartered?
Luxonus is headquartered in Kawasaki, Japan.
-
What industry is Luxonus in?
Luxonus’s primary industry is Diagnostic Equipment.
-
Is Luxonus a private or public company?
Luxonus is a Private company.
-
What is Luxonus’s current revenue?
The current revenue for Luxonus is
. -
How much funding has Luxonus raised over time?
Luxonus has raised $10.4M.
-
Who are Luxonus’s investors?
IT-Farm, 360ip Japan, Mirai Creation Capital, Mirai Souzou Investments, and Future Venture Capital are 5 of 16 investors who have invested in Luxonus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »